Dermatology, MOHS-Micrographic Surgery · Dayton, OH
NPI
1144248493
Since 2006
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5300 Far Hills Ave.
Dayton, OH, 45429
Phone (937) 433-7536
Groups this clinician bills Medicare through
Medicare paid, 2024
$842K
2,849 services
Medicare patients, 2024
859
Average age 77
Drug cost, 2024
$127K
2,746 prescriptions
Company payments, 2025
$38.44
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Phillip K Hall was code 17311 (mohs surgery), 948 times for 736 patients. In total Phillip K Hall billed 2,849 services in 73 codes, and Medicare paid $842K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17311 Mohs Surgery | Office | 948 | 736 | $419.26 | $397K |
| 17312 Mohs Surgery | Office | 488 | 325 | $301.01 | $147K |
| 13132 Wound Repair - All Levels | Office | 294 | 270 | $173.63 | $51K |
| 17313 Mohs Surgery | Office | 141 | 109 | $403.67 | $57K |
| 13121 Wound Repair - All Levels | Office | 102 | 96 | $161.09 | $16K |
| 11102 Skin Biopsy | Office | 90 | 86 | $39.16 | $3,525 |
| 88331 Surgical Pathology Examination | Office | 55 | 49 | $74.60 | $4,103 |
| 99213 Office E&M - Established | Office | 55 | 38 | $55.86 | $3,072 |
| 17003 Destruction Skin Lesion | Office | 53 | 11 | $4.64 | $246 |
| 13152 Wound Repair - All Levels | Office | 53 | 53 | $183.93 | $9,748 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 48 | 15 | $0.72 | $34.35 |
| 13122 Wound Repair - All Levels | Office | 45 | 43 | $94.07 | $4,233 |
| 14041 Skin Grafting | Office | 35 | 34 | $654.31 | $23K |
| 14060 Skin Grafting | Office | 34 | 34 | $547.77 | $19K |
| 17314 Mohs Surgery | Office | 31 | 24 | $289.74 | $8,982 |
By year: 2022 $850K for 3,201 services; 2023 $688K for 2,466 services; 2024 $842K for 2,849 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88331 Surgical Pathology Examination | 55 | 49 | $74.60 | $4,103 |
Medicare prescription drug claims, 2024
In 2024, the drug Phillip K Hall prescribed most often to Medicare patients was Cephalexin, with 1,132 prescriptions and refills. In total Phillip K Hall wrote 2,746 Medicare prescriptions that cost $127K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 1,132 | 1,132 | 984 | $4,795 |
| Mupirocin Generic | 1,028 | 1,039 | 744 | $6,358 |
| Clindamycin Hcl Generic | 172 | 174 | 152 | $795 |
| Doxycycline Hyclate Generic | 102 | 102 | 86 | $631 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 40 | 40 | 39 | $108 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 | 33 | 26 | $529 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 | 26 | 22 | $78.08 |
| Acitretin Generic | 24 | 28 | Under 11 | $21K |
| Imiquimod Generic | 21 | 25 | 18 | $794 |
| Levofloxacin Generic | 19 | 19 | 19 | $97.93 |
| Tramadol Hcl Generic | 19 | 19 | 18 | $26.23 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 15 | 15 | 14 | $58.81 |
| Fluorouracil Generic | 14 | 14 | 13 | $1,598 |
| Azithromycin Generic | 12 | 12 | Under 11 | $19.31 |
Brand drugs: 12 claims; generic drugs: 2,734 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phillip K Hall $38.44 ($38.44 in general payments such as food, travel and fees) from 2 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $19.49.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $19.49 |
| Incyte Corporation INCY | 1 | $18.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.